Clinical Trials · NCT02060383
Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Novartis Pharmaceuticals
- Enrollment
- 249
- Start date
- May 2014
- Locations
- 43 sites, 12 countries
- Primary endpoint
- Change in HbA1c From Randomization to Approximately 16 Weeks